Global Commission Presents Nuanced Approach for Defining Clinical Obesity
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- A global commission endorsed by 75 medical organizations around the world and published online Jan. 14 in The Lancet Diabetes & Endocrinology, presents a nuanced approach to defining clinical obesity as a chronic illness resulting from the effect of excess adiposity on organ and tissue function.
Francesco Rubino, M.D., from King's College London, and colleagues reviewed the available evidence and developed criteria for clinical obesity to aid clinical decision-making and prioritize therapeutic interventions.
The authors define obesity as a condition characterized by excess adiposity, with or without abnormal distribution or function of adipose tissue, and with causes that are multifactorial and incompletely understood. Clinical obesity can result in severe end-organ damage, causing life-altering and potentially life-threatening complications. Preclinical obesity is defined as a state of excess adiposity with preserved function of other tissues and organs and a varying risk for developing clinical obesity and several other noncommunicable diseases. Body mass index should be used as a surrogate measure of health risk at a population level, for epidemiological studies, or for screening purposes, rather than as an individual measure of health. The diagnosis of clinical obesity requires evidence of reduced organ or tissue function due to obesity or substantial, age-adjusted limitations of daily activities reflecting the specific effect of obesity on basic activities of daily living or both. Timely, evidence-based treatment should be provided to people with clinical obesity, with the aim of improving clinical manifestations of obesity and preventing end-organ damage.
"The question of whether obesity is a disease is flawed because it presumes an implausible all-or-nothing scenario where obesity is either always a disease or never a disease," Rubino said in a statement. "Evidence, however, shows a more nuanced reality."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
2002 to 2022 Saw Increase in Teen Handgun Carrying in Florida
MONDAY, July 7, 2025 -- In Florida, adolescent handgun carrying is increasing, while handgun carrying in school, favorable attitudes toward handgun carrying in school, and ease of...
Adiposity-Linked Breast Cancer Risk Higher for Women With CVD
MONDAY, July 7, 2025 -- Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer, according to a study published online July...
Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
MONDAY, July 7, 2025 -- There does not appear to be a causal relationship between most previously suspected pharmacologic triggers and the risk for microscopic colitis (MC)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.